The startup operates a network of infusion centers that streamline patient care by coordinating treatment logistics with insurance providers and pharmaceutical manufacturers. This approach enhances patient comfort and affordability while ensuring efficient management of health services throughout the treatment process.
Funding
Funding not disclosed
Founders
Product
Problem
Patients requiring intravenous (IV) infusions often face challenges such as high costs, fragmented care coordination, and inconvenient treatment locations, typically relying on expensive hospital settings or managing multiple providers independently. This can lead to a disjointed and less patient-centric experience.
Solution
Immersiv Health operates a network of specialized infusion centers designed to optimize the patient experience and reduce the overall cost of care. These centers coordinate treatment logistics, including insurance pre-authorization and communication with pharmaceutical manufacturers and referring physicians, to streamline the process for patients. Immersiv Health provides convenient and comfortable infusion settings, aiming to create a more personalized and accessible healthcare experience. By managing the administrative burden and offering a supportive environment, Immersiv Health allows patients to focus on their treatment and overall well-being.
Target Audience
The primary target audience includes patients with chronic conditions requiring IV infusion therapy, as well as physicians and payors seeking quality, convenient, and cost-effective infusion solutions for their patients.
Features
- Conveniently located infusion centers to fit seamlessly into patients' daily lives
- Coordination with insurance providers to lower out-of-pocket costs
- Streamlined referral process and management of prior authorizations
- Coordination with the patient's physician and care team
- Comfortable and calming infusion suites
- Personalized care with warm and understanding clinicians and staff
- Preventative care plans and extensive health and treatment outcome assessments